The Fibrosis Innovation Group (FIG) is modeled after highly successful innovative units within biotechnology companies and non-profit research institutes.
The FIG streamlines and enriches existing capabilities at the Anschutz Medical Campus with a focus on fibrosis research.
Innovative units within this group:
Cell-Based Disease Modeling Unit
In Vivo Disease Modeling Unit
Fibrosis Quantification Unit
Redox Biology Unit
Computational Biology Unit